Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;

Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;

Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study Edgar Denova-Gutiérrez; Berenice Rivera-Paredez; Amado D. Quezada-Sánchez; Brianda I. Armenta-Guirado; Paloma Muñoz-Aguirre; Yvonne N. Flores; Rafael Velázquez-Cruz; Jorge Salmerón;